Search

Your search keyword '"Luong, TuVinh"' showing total 29 results
Start Over Author "Luong, TuVinh"
29 results on '"Luong, TuVinh"'

3. Supplementary figures S1-4 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, primary, Pipinikas, Chistodoulos, primary, Feber, Andrew, primary, Morris, Tiffany, primary, Francis, Joshua, primary, Oukrif, Dahmane, primary, Mandair, Dalvinder, primary, Pericleous, Marinos, primary, Mohmaduvesh, Mullan, primary, Serra, Stefano, primary, Ogunbiyi, Olagunju, primary, Novelli, Marco, primary, Luong, TuVinh, primary, Asa, Sylvia L., primary, Kulke, Matthew, primary, Toumpanakis, Christos, primary, Meyer, Tim, primary, Caplin, Martyn, primary, Meyerson, Matthew, primary, Beck, Stephan, primary, and Thirlwell, Christina, primary

Published
2023
Full Text
View/download PDF

4. supplemental figure and table legend from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, primary, Pipinikas, Chistodoulos, primary, Feber, Andrew, primary, Morris, Tiffany, primary, Francis, Joshua, primary, Oukrif, Dahmane, primary, Mandair, Dalvinder, primary, Pericleous, Marinos, primary, Mohmaduvesh, Mullan, primary, Serra, Stefano, primary, Ogunbiyi, Olagunju, primary, Novelli, Marco, primary, Luong, TuVinh, primary, Asa, Sylvia L., primary, Kulke, Matthew, primary, Toumpanakis, Christos, primary, Meyer, Tim, primary, Caplin, Martyn, primary, Meyerson, Matthew, primary, Beck, Stephan, primary, and Thirlwell, Christina, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table 2 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, primary, Pipinikas, Chistodoulos, primary, Feber, Andrew, primary, Morris, Tiffany, primary, Francis, Joshua, primary, Oukrif, Dahmane, primary, Mandair, Dalvinder, primary, Pericleous, Marinos, primary, Mohmaduvesh, Mullan, primary, Serra, Stefano, primary, Ogunbiyi, Olagunju, primary, Novelli, Marco, primary, Luong, TuVinh, primary, Asa, Sylvia L., primary, Kulke, Matthew, primary, Toumpanakis, Christos, primary, Meyer, Tim, primary, Caplin, Martyn, primary, Meyerson, Matthew, primary, Beck, Stephan, primary, and Thirlwell, Christina, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 4 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, primary, Pipinikas, Chistodoulos, primary, Feber, Andrew, primary, Morris, Tiffany, primary, Francis, Joshua, primary, Oukrif, Dahmane, primary, Mandair, Dalvinder, primary, Pericleous, Marinos, primary, Mohmaduvesh, Mullan, primary, Serra, Stefano, primary, Ogunbiyi, Olagunju, primary, Novelli, Marco, primary, Luong, TuVinh, primary, Asa, Sylvia L., primary, Kulke, Matthew, primary, Toumpanakis, Christos, primary, Meyer, Tim, primary, Caplin, Martyn, primary, Meyerson, Matthew, primary, Beck, Stephan, primary, and Thirlwell, Christina, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 1 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, primary, Pipinikas, Chistodoulos, primary, Feber, Andrew, primary, Morris, Tiffany, primary, Francis, Joshua, primary, Oukrif, Dahmane, primary, Mandair, Dalvinder, primary, Pericleous, Marinos, primary, Mohmaduvesh, Mullan, primary, Serra, Stefano, primary, Ogunbiyi, Olagunju, primary, Novelli, Marco, primary, Luong, TuVinh, primary, Asa, Sylvia L., primary, Kulke, Matthew, primary, Toumpanakis, Christos, primary, Meyer, Tim, primary, Caplin, Martyn, primary, Meyerson, Matthew, primary, Beck, Stephan, primary, and Thirlwell, Christina, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 3 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, primary, Pipinikas, Chistodoulos, primary, Feber, Andrew, primary, Morris, Tiffany, primary, Francis, Joshua, primary, Oukrif, Dahmane, primary, Mandair, Dalvinder, primary, Pericleous, Marinos, primary, Mohmaduvesh, Mullan, primary, Serra, Stefano, primary, Ogunbiyi, Olagunju, primary, Novelli, Marco, primary, Luong, TuVinh, primary, Asa, Sylvia L., primary, Kulke, Matthew, primary, Toumpanakis, Christos, primary, Meyer, Tim, primary, Caplin, Martyn, primary, Meyerson, Matthew, primary, Beck, Stephan, primary, and Thirlwell, Christina, primary

Published
2023
Full Text
View/download PDF

9. PTH-1 Small-bowel neuroendocrine tumours: the role of double-balloon-enteroscopy. A case series from a tertiary referral centre

Author

Magalhães, Rui de Sousa, primary, Murino, Alberto, additional, Skamnelos, Alexandros, additional, Cahuin, Rocio Chacchi, additional, Telese, Andrea, additional, Phillips, Edward, additional, Laskaratos, Faidon-Marios, additional, Luong, TuVinh, additional, Watkins, Jennifer, additional, Koukias, Nikolaos, additional, Raymond, Regina, additional, Lazaridis, Nikolaos, additional, Mandair, Dalvinder, additional, Toumpanakis, Christos, additional, Caplin, Martyn E, additional, and Despott, Edward J, additional

Published
2021
Full Text
View/download PDF

11. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within milan criteria

Author

Parisi, Ioanna, Tsochatzis, Emmanuel, Wijewantha, Hasitha, Rodríguez-Perálvarez, Manuel, Luca, Laura De, Manousou, Pinelopi, Fatourou, Evangelia, Pieri, Giulia, Papastergiou, Vassilios, Davies, Neil, Yu, Dominic, Luong, TuVinh, Dhillon, Amar Paul, Thorburn, Douglas, Patch, David, OʼBeirne, James, Meyer, Tim, and Burroughs, Andrew K.

Published
2014
Full Text
View/download PDF

13. P366 Management of complex endoscopic lesions through an advanced-endoscopy multidisciplinary team-meeting: experience from a tertiary centre

Author

Murino, Alberto, primary, Lazaridis, Nikolaos, additional, Skamnelos, Alexandros, additional, Koukias, Nikolaos, additional, Coppo, Claudia, additional, Costa, Deborah, additional, Varcada, Massimo, additional, Watkins, Jennifer, additional, Wylie, Peter, additional, Luong, TuVinh, additional, Raymond, Regina, additional, Bailey, Alara, additional, Hart, Colin, additional, Planche, Katie, additional, and Despott, Edward J, additional

Published
2021
Full Text
View/download PDF

16. Duodenal neuroendocrine neoplasms with unexpectedly aggressive behaviour: Challenging the "watch and wait" approach.

Author

Ratnayake, Gowri M., Srirajaskanthan, Raj, Luong, TuVinh, Gnanasegaran, Gopinath, and Toumpanakis, Christos

Subjects
NEUROENDOCRINE tumors, DUODENAL tumors, MERKEL cell carcinoma, TUMORS
Abstract

The incidence of duodenal neuroendocrine neoplasms has risen over the past decades as a result of the wide availability of endoscopy and associated expertise. Although it is considered that tumour size greater than 10 mm, higher tumour grade and/or location in relation to the ampulla of Vater represent the main risk factors for local or distant metastases, we describe two cases of well differentiated grade 1 and grade 2 neuroendocrine tumours, which measured < 10 mm at the time of diagnosis but had an aggressive course during follow‐up. Furthermore, we also summarise the available therapeutic strategies for the management of small, low grade, non‐functioning, non‐ampullary duodenal neuroendocrine neoplasms. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

17. Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease

Author

Buzzetti, Elena, Hall, Andrew, Ekstedt, Mattias, Manuguerra, Roberta, Misas, Marta Guerrero, Covelli, Claudia, Leandro, Gioacchino, Luong, TuVinh, Kechagias, Stergios, Manesis, Emanuel K., Pinzani, Massimo, Dhillon, Amar P., Tsochatzis, Emmanuel A., Buzzetti, Elena, Hall, Andrew, Ekstedt, Mattias, Manuguerra, Roberta, Misas, Marta Guerrero, Covelli, Claudia, Leandro, Gioacchino, Luong, TuVinh, Kechagias, Stergios, Manesis, Emanuel K., Pinzani, Massimo, Dhillon, Amar P., and Tsochatzis, Emmanuel A.

Abstract

Background Collagen proportionate area (CPA) measurement is a technique that quantifies fibrous tissue in liver biopsies by measuring the amount of collagen deposition as a proportion of the total biopsy area. CPA predicts clinical outcomes in patients with HCV and can sub-classify cirrhosis. Aim To test the ability of CPA to quantify fibrosis and predict clinical outcomes in patients with NAFLD. Methods We assessed consecutive patients with biopsy-proven NAFLD from three European centres. Clinical and laboratory data were collected at baseline and at the time of the last clinical follow-up or death. CPA was performed at two different objective magnifications, whole biopsy macro and x4 objective magnification, named standard (SM) and high (HM) magnification respectively. The correlation between CPA and liver stiffness was assessed in a sub-group of patients. Results Of 437 patients, 32 (7.3%) decompensated and/or died from liver-related causes during a median follow-up of 103 months. CPA correlated with liver stiffness and liver fibrosis stage across the whole spectrum of fibrosis. HM CPA was significantly higher than SM CPA in stages F0-F3 but similar in cirrhosis, reflecting a higher ability to capture pericellular/perisinusoidal fibrosis at early stages. Age at baseline (HR: 1.04, 95% CI: 1.01-1.08), HM CPA (HR: 1.04 per 1% increase, 95% CI: 1.01-1.08) and presence of advanced fibrosis (HR: 15.4, 95% CI: 5.02-47.84) were independent predictors of liver-related clinical outcomes at standard and competing risk multivariate Cox-regression analysis. Conclusions CPA accurately measures fibrosis and is an independent predictor of clinical outcomes in NAFLD; hence it merits further evaluation as a surrogate endpoint in clinical trials., Funding Agencies|European Association for the Study of the Liver; AIGO (Associazione Italiana Gastroenterologi Ospedalieri); M.I.M.I. (Montecatini Interactive Medicine International)

Published
2019
Full Text
View/download PDF

18. Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms

Author

Laskaratos, Faidon-Marios, primary, Mandair, Dalvinder, additional, Hall, Andrew, additional, Alexander, Sarah, additional, von Stempel, Conrad, additional, Bretherton, Josephine, additional, Luong, TuVinh, additional, Watkins, Jennifer, additional, Ogunbiyi, Olagunju, additional, Rombouts, Krista, additional, Caplin, Martyn, additional, and Toumpanakis, Christos, additional

Published
2019
Full Text
View/download PDF

19. Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease

Author

Buzzetti, Elena, primary, Hall, Andrew, additional, Ekstedt, Mattias, additional, Manuguerra, Roberta, additional, Guerrero Misas, Marta, additional, Covelli, Claudia, additional, Leandro, Gioacchino, additional, Luong, TuVinh, additional, Kechagias, Stergios, additional, Manesis, Emanuel K., additional, Pinzani, Massimo, additional, Dhillon, Amar P., additional, and Tsochatzis, Emmanuel A., additional

Published
2019
Full Text
View/download PDF

20. IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection

Author

Pallett, Laura J., Davies, Jessica, Colbeck, Emily J., Robertson, Francis, Hansi, Navjyot, Easom, Nicholas J.W., Burton, Alice R., Stegmann, Kerstin A., Schurich, Anna, Swadling, Leo, Gill, Upkar S., Male, Victoria, Luong, TuVinh, Gander, Amir, Davidson, Brian R., Kennedy, Patrick T.F., Maini, Mala K., and Wellcome Trust

Subjects
Hepatitis B virus, T-Lymphocytes, Programmed Cell Death 1 Receptor, Immunology, Receptors, Antigen, T-Cell, CD8-Positive T-Lymphocytes, Granzymes, Hepatitis B, Chronic, Antigens, CD, Transforming Growth Factor beta, Humans, Antigens, Research Articles, 11 Medical and Health Sciences, Cell Proliferation, Receptors, CXCR6, Interleukin-15, Brief Definitive Report, Models, Immunological, Autocrine Communication, Phenotype, Liver, Interleukin-2, Receptors, Virus, Receptors, Chemokine, Immunologic Memory
Abstract

Pallett et al. identify tissue-resident memory CD8 T cells compartmentalized in the healthy human liver that expand in controlled hepatotropic infection and can swiftly produce antiviral cytokines. This prototype may inform the development of liver-targeted T cell immunotherapy., The liver provides a tolerogenic immune niche exploited by several highly prevalent pathogens as well as by primary and metastatic tumors. We have sampled healthy and hepatitis B virus (HBV)–infected human livers to probe for a subset of T cells specialized to overcome local constraints and mediate immunity. We characterize a population of T-betloEomesloBlimp-1hiHobitlo T cells found within the intrahepatic but not the circulating memory CD8 T cell pool expressing liver-homing/retention markers (CD69+CD103+ CXCR6+CXCR3+). These tissue-resident memory T cells (TRM) are preferentially expanded in patients with partial immune control of HBV infection and can remain in the liver after the resolution of infection, including compartmentalized responses against epitopes within all major HBV proteins. Sequential IL-15 or antigen exposure followed by TGFβ induces liver-adapted TRM, including their signature high expression of exhaustion markers PD-1 and CD39. We suggest that these inhibitory molecules, together with paradoxically robust, rapid, cell-autonomous IL-2 and IFNγ production, equip liver CD8 TRM to survive while exerting local noncytolytic hepatic immunosurveillance.

Published
2017

22. The workload and impact of a dedicated cancer of unknown primary (CUP) service on patients with imaging suggestive of metastatic disease

Author

Mclaren, Alistair, primary, Ulahannan, Danny, additional, Keen, Emily, additional, Stewart, Grant, additional, Bell, James, additional, Planche, Katie, additional, Power, Niall, additional, Navalkissoor, Shaunak, additional, Craig, Rachel, additional, Luong, TuVinh, additional, Watkins, Jennifer, additional, Clark, Ian, additional, and Gillmore, Roopinder, additional

Published
2017
Full Text
View/download PDF

23. IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection

Author

Pallett, Laura J., primary, Davies, Jessica, additional, Colbeck, Emily J., additional, Robertson, Francis, additional, Hansi, Navjyot, additional, Easom, Nicholas J.W., additional, Burton, Alice R., additional, Stegmann, Kerstin A., additional, Schurich, Anna, additional, Swadling, Leo, additional, Gill, Upkar S., additional, Male, Victoria, additional, Luong, TuVinh, additional, Gander, Amir, additional, Davidson, Brian R., additional, Kennedy, Patrick T.F., additional, and Maini, Mala K., additional

Published
2017
Full Text
View/download PDF

24. Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases

Author

Karpathakis, Anna, primary, Dibra, Harpreet, additional, Pipinikas, Christodoulos, additional, Feber, Andrew, additional, Morris, Tiffany, additional, Francis, Joshua, additional, Oukrif, Dahmane, additional, Mandair, Dalvinder, additional, Pericleous, Marinos, additional, Mohmaduvesh, Mullan, additional, Serra, Stefano, additional, Ogunbiyi, Olagunju, additional, Novelli, Marco, additional, Luong, TuVinh, additional, Asa, Sylvia L, additional, Kulke, Matthew, additional, Toumpanakis, Christos, additional, Meyer, Tim, additional, Caplin, Martyn, additional, Beck, Stephan, additional, and Thirlwell, Christina, additional

Published
2017
Full Text
View/download PDF

25. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

Author

Karpathakis, Anna, primary, Dibra, Harpreet, additional, Pipinikas, Chistodoulos, additional, Feber, Andrew, additional, Morris, Tiffany, additional, Francis, Joshua, additional, Oukrif, Dahmane, additional, Mandair, Dalvinder, additional, Pericleous, Marinos, additional, Mohmaduvesh, Mullan, additional, Serra, Stefano, additional, Ogunbiyi, Olagunju, additional, Novelli, Marco, additional, Luong, TuVinh, additional, Asa, Sylvia L., additional, Kulke, Matthew, additional, Toumpanakis, Christos, additional, Meyer, Tim, additional, Caplin, Martyn, additional, Meyerson, Matthew, additional, Beck, Stephan, additional, and Thirlwell, Christina, additional

Published
2016
Full Text
View/download PDF

27. Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes

Author

Manousou, Pinelopi, primary, Cholongitas, Evangelos, additional, Samonakis, Dimitrios, additional, Tsochatzis, Emmanuel, additional, Corbani, Alice, additional, Dhillon, A P, additional, Davidson, Janice, additional, Rodríguez-Perálvarez, Manuel, additional, Patch, D, additional, O'Beirne, J, additional, Thorburn, D, additional, Luong, TuVinh, additional, Rolles, K, additional, Davidson, Brian, additional, McCormick, P A, additional, Hayes, Peter, additional, and Burroughs, Andrew K, additional

Published
2013
Full Text
View/download PDF

28. Neuroendocrine tumours and pregnancy: Real‐world data from an European Neuroendocrine Tumour Centre of Excellence.

Author

Ratnayake, Gowri M., Shekhda, Kalyan Mansukhbhai, Glover, Thomas, Al‐Obudi, Yasser, Hayes, Aimee, Armonis, Panagiotis, Mandair, Dalvinder, Khoo, Bernard, Luong, TuVinh, Toumpanakis, Christos, Grossman, Ashley, and Caplin, Martyn

Subjects
*PREGNANCY outcomes, *NEUROENDOCRINE tumors, *PROGESTERONE receptors, *PREGNANT women, *COMPUTED tomography
Abstract

Neuroendocrine neoplasms (NENs) arise from the diffuse endocrine system and have been considered to be rare. However, the incidence and prevalence of these tumours have increased in recent years, and they are being seen in younger patients including women in the reproductive age group. Due to the paucity of data, diagnostic and therapeutic strategies in managing such tumours during pregnancy can be challenging to both treating physicians and patients. This article describes the experience and outcomes of managing pregnant women with NEN at a European Neuroendocrine Tumour Society (ENETS) Centre of Excellence. In this retrospective analysis, we evaluated a total of 22 pregnancies in 18 pregnant women with concurrent diagnoses of NENs who were managed at Royal Free Hospital ENETS Centre of Excellence throughout their pregnancy. These were identified from our tumour registry of 3500 NEN patients between 2015 and 2023. Cross‐sectional imaging (computed tomography (CT)/magnetic resonance imaging (MRI)), pre‐ and post‐pregnancy, for each patient was reviewed by an experienced radiologist. Tumour growth rate (TGR) was calculated using the formula: TGR = 100 × [exp (TG) − 1]; TG. [3 × log (D2/D1)]/time (months), where D1 is the tumour size at date 1; D2 is the tumour size at date 2; and time (months) = (Date 2 − Date 1 + 1)/30.44. Tumour growth rate pre‐conception (TGRpc) and tumour growth rate post‐partum (TGRpp) were calculated for each patient. In a sub‐group of patients, positivity for oestrogen and progesterone receptors were analysed on the tumour tissue to evaluate whether the presence of these receptors affected tumour progression during the pregnancy. We also reviewed the pregnancy outcome in patients treated with somatostatin analogues during pregnancy. We analysed the data of a total 22 pregnancy encounters in 18 women: 15 pregnancies (68%) preceded the diagnosis of the NEN, whereas the diagnosis of NEN was made during pregnancy or in the post‐partum period in 5 (23%) and 2 (9%) pregnancies respectively. Eight patients (44%) had a diagnosis of a pancreatic NEN, whereas 5 (28%) were diagnosed with mid‐gut NENs, and a further 5 at other sites. The majority of the patients (n = 12, 67%) had evidence of metastatic disease at the time of diagnosis. Most pregnancies had a successful outcome (n = 19, 86%), whereas 3 patients (14%) had miscarriages in the 1st trimester. Five patients in total of 6 pregnancies were treated with somatostatin analogues as monotherapy during the pregnancy, and all of them had stable disease after pregnancy. All of them delivered healthy babies without any side effects or complications due to therapy. The average TGRpc was −0.8% (n = 5) and the average TGRpp was +0.96% (n = 6); 2 patients who did not have suitable targets for calculation of TGRpc developed new lesions suggesting disease progression. Moreover, 2 of the 4 patients who have had both pre‐conception and post‐pregnancy scans showed an increase in TGRpp compared to TGRpc. The management of NENs during pregnancy should be multidisciplinary with an individualised approach to each patient. Somatostatin analogues appear to be safe during pregnancy, though further robust studies are needed. Pregnancy per se may accelerate tumour progression, and patients should be counselled regarding this possibility. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. IL-2 high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection.

Author

Pallett LJ, Davies J, Colbeck EJ, Robertson F, Hansi N, Easom NJW, Burton AR, Stegmann KA, Schurich A, Swadling L, Gill US, Male V, Luong T, Gander A, Davidson BR, Kennedy PTF, and Maini MK

Subjects
Antigens immunology, Antigens, CD metabolism, Autocrine Communication drug effects, CD8-Positive T-Lymphocytes drug effects, Cell Proliferation drug effects, Granzymes metabolism, Hepatitis B virus drug effects, Hepatitis B, Chronic immunology, Hepatitis B, Chronic pathology, Hepatitis B, Chronic virology, Humans, Immunologic Memory drug effects, Interleukin-15 pharmacology, Liver drug effects, Liver pathology, Phenotype, Programmed Cell Death 1 Receptor metabolism, Receptors, Antigen, T-Cell metabolism, Receptors, CXCR6, Receptors, Chemokine metabolism, Receptors, Virus metabolism, Transforming Growth Factor beta pharmacology, CD8-Positive T-Lymphocytes immunology, Interleukin-2 metabolism, Liver immunology, Liver virology
Abstract

The liver provides a tolerogenic immune niche exploited by several highly prevalent pathogens as well as by primary and metastatic tumors. We have sampled healthy and hepatitis B virus (HBV)-infected human livers to probe for a subset of T cells specialized to overcome local constraints and mediate immunity. We characterize a population of T-bet lo Eomes lo Blimp-1 hi Hobit lo T cells found within the intrahepatic but not the circulating memory CD8 T cell pool expressing liver-homing/retention markers (CD69 + CD103 + CXCR6 + CXCR3 + ). These tissue-resident memory T cells (T RM ) are preferentially expanded in patients with partial immune control of HBV infection and can remain in the liver after the resolution of infection, including compartmentalized responses against epitopes within all major HBV proteins. Sequential IL-15 or antigen exposure followed by TGFβ induces liver-adapted T RM , including their signature high expression of exhaustion markers PD-1 and CD39. We suggest that these inhibitory molecules, together with paradoxically robust, rapid, cell-autonomous IL-2 and IFNγ production, equip liver CD8 T RM to survive while exerting local noncytolytic hepatic immunosurveillance., (© 2017 Pallett et al.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results